3 December 2019

The FUTURE biobank consists of residual biomaterial (serum and plasma) from the FUTURE study. The “Follow-Up of Transient ischemic attack and stroke patients and Unelucidated Risk factor Evaluation” (FUTURE) study is a prospective cohort study of prognosis of stroke in young adults. This study comprised patients aged 18 through 50 years with a TIA, ischemic stroke or intracerebral hemorrhage (1980-2010). The associated clinical data consists of baseline and clinical characteristics, including demographic data, stroke subtype and vascular risk factors.
  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud biobank

Related news items


First implications of the Radboud Biobank new business model

15 July 2025

It was communicated in an earlier news item that the Radboudumc Board of Directors decided to change the Radboud Biobank business model.

read more

Relocation of Radboud Biobank samples to Central Freezing Facility

15 July 2025

The Radboud Biobank has now transferred almost all stored samples to the central freezing facility.

read more

Standardized Radboud Biobank procedures for sample handling in Elabgids

15 July 2025

The Radboud Biobank is currently preparing to include all standardized Radboud Biobank procedures for sample handling in the eLabgids.

read more

Temporary new location Radboud Biobank Office

15 July 2025

The Radboud Biobank office has moved to a temporary new location: route 832 - M325.04.255 (building F).

read more

Europe Biobank Week 2025

15 July 2025

The Europe Biobank Week 2025 was a great success for the Dutch biobank community with a strong presence of Dutch biobanking and biomedical research.

read more

National Biobanks & Collections Dag 2025

6 May 2025

The second edition of the National Biobanks & Collections Day took place on March 27, 2025, in Nijmegen and attracted 150 participants from all over the Netherlands.

read more